Molecular link traced from gene to late-onset retinal degeneration

Clinical trial planning underway to test the widely used diabetes drug metformin as a preventive treatment for the blinding eye disease. Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health […]